Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens.
about
Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune responseBiological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalisIdentification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutantA major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serumSynthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.Moraxella catarrhalis: from emerging to established pathogen.Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art reviewFunctional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.Characterization of the first molluscicidal lipopolysaccharide from Moraxella osloensis.Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.Moraxella catarrhalis activates murine macrophages through multiple toll like receptors and has reduced clearance in lungs from TLR4 mutant miceMutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.Revisiting the interaction between the chaperone Skp and lipopolysaccharideHuman immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides.Vaccine targets against Moraxella catarrhalis.Branhamella catarrhalis: an organism gaining respect as a pathogenGalactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.Comparative Genomic Analyses of the Moraxella catarrhalis Serosensitive and Seroresistant Lineages Demonstrate Their Independent Evolution.Identification of two late acyltransferase genes responsible for lipid A biosynthesis in Moraxella catarrhalis.Late acyltransferase genes lpxX and lpxL jointly contribute to the biological activities of Moraxella catarrhalis.Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.Rapid method for differentiating strains of Branhamella catarrhalisComparison of two silver staining techniques for detecting lipopolysaccharides in polyacrylamide gelsEpidemiological typing of Moraxella catarrhalis by using DNA probes.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Q24650974-4A7105EA-1446-418D-A8EC-4B117B3355A3Q24684942-8779AC0B-1912-48D6-8B89-870FB2CB7A91Q31015760-4A5B6141-14CC-4046-BD15-83812D21C236Q33596480-FFCF0715-5971-4879-9B8F-333DC507FA19Q33597864-395E8060-3B17-4509-A78B-97E77A0AD5BAQ33599918-F2B6D293-D9A2-4154-8384-A6CC4F3307B2Q33753424-2DD6B7DA-026D-48F1-98BC-F0AD2B59384CQ33755304-2357A8BC-98FD-41AF-90C4-BC11E5133F3DQ33768943-2542C10E-CB7B-4895-8F84-938CF19450A7Q33906182-90263A80-5C25-473E-96FE-1E306C7D7DB0Q33975684-6B91EA91-E330-4706-907E-812E2EBA924BQ34006231-CDD1D722-585A-4549-86B5-9DC2A5CF3722Q34117703-7DD9C392-3AB8-49DA-A91C-AE491F37E258Q34183386-5AD3B388-1ED9-4CAE-9E5F-DD55F90358A6Q34203235-5B2D840E-349D-4B45-BE27-01DCD1A61CB3Q34231852-B33C91EB-7472-4CD2-85D9-1770AB7BC010Q34291110-84E58573-BFA7-4111-B668-C49CE3449AF7Q35029651-DBE6C8C3-1DB4-4C87-A3B5-EC552BE91E8AQ35221766-64805B6B-875C-4290-9EF3-249C5144A629Q35223984-09024344-4980-41AA-9C6E-B0E256BCF41CQ35226903-3BB0350F-39A0-445A-B7BC-383AC754BB9BQ36483998-08EF5B44-DB3C-4AD1-89BC-D560DB4113A8Q36636508-F8A945FA-086F-4DE4-9C4E-AA912909EC5AQ36845123-CC3D408C-5BC7-4FA6-A05A-B9B371CCC7C1Q36882169-82C05D49-7F22-4200-A120-1191E29727B4Q36979798-0B44AB00-AC34-4D24-8917-458C7A1F4D4DQ37006478-7D3220C1-DE1D-484B-AC2A-3505E53BB002Q37355837-C5C25104-9C25-4092-AFB6-A56DCD53E3B3Q39404572-06BAB6E2-5D5D-491B-A4E5-C9B97DA42E00Q39695256-0B723A21-CC73-4505-B489-1A8C170E9458Q40174666-D03D7A53-36BD-48EB-95CF-E22942B2C260Q53701548-629D19C8-05DB-4138-A7D7-410051E4CE7F
P2860
Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Serological typing of Branhame ...... f lipopolysaccharide antigens.
@en
type
label
Serological typing of Branhame ...... f lipopolysaccharide antigens.
@en
prefLabel
Serological typing of Branhame ...... f lipopolysaccharide antigens.
@en
P2093
P2860
P1476
Serological typing of Branhame ...... f lipopolysaccharide antigens.
@en
P2093
Van Den Abeele AM
Verschraegen G
P2860
P304
P407
P577
1990-02-01T00:00:00Z